⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL668 | 0.93 | — | — | |
| Hydrochloric Acid SCHEMBL1673138 | 0.86 | — | — | |
| SCHEMBL9642247 | 0.86 | — | — | |
| SCHEMBL11334441 | 0.86 | — | — | |
| SCHEMBL25388502 | 0.86 | — | — | |
| SCHEMBL25420124 | 0.86 | — | — | |
| SCHEMBL5248398 | 0.86 | — | — | |
| SCHEMBL1394407 | 0.86 | — | — | |
| Water SCHEMBL21050625 | 0.86 | — | — | |
| SCHEMBL28404506 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11111261-B2 | Iron complex compounds for therapeutic use | PHARMACOSMOS HOLDING A/S (DK) | 2021-09-07 | — | — | US | claimed |
| EP-3681539-A1 | IRON COMPLEX COMPOUNDS FOR THERAPEUTIC USE | Pharmacosmos Holding A/S (DK) | 2020-07-22 | — | — | EP | claimed |
| WO-2019048674-A1 | IRON COMPLEX COMPOUNDS FOR THERAPEUTIC USE | PHARMACOSMOS HOLDING A/S (DK) | 2019-03-14 | — | — | WO | claimed |
| EP-1414550-A1 | METHOD AND APPARATUS FOR NO X? AND SO 2? REMOVAL | Cansolv Technologies Inc. (CA) | 2004-05-06 | — | — | EP | claimed |
| WO-2003013701-A1 | METHOD AND APPARATUS FOR NOX AND SO2 REMOVAL | CANSOLV TECHNOLOGIES INC. (CA) | 2003-02-20 | — | — | WO | claimed |
| EP-4380581-A1 | IRON COMPLEX COMPOUNDS FOR SUBCUTANEOUS USE IN THERAPY OF IRON DEFICIENCY IN COMPANION ANIMALS | Pharmacosmos Holding A/S (DK) | 2024-06-12 | — | — | EP | disclosed |
| CN-118019542-A | Iron complex compounds for subcutaneous use in treating iron deficiency in companion animals | 法码科思莫斯控股有限公司 | 2024-05-10 | — | — | CN | disclosed |
| WO-2023012242-A1 | IRON COMPLEX COMPOUNDS FOR SUBCUTANEOUS USE IN THERAPY OF IRON DEFICIENCY IN COMPANION ANIMALS | PHARMACOSMOS HOLDING A/S (DK) | 2023-02-09 | — | — | WO | disclosed |
| US-11111261-B2 | Iron complex compounds for therapeutic use | PHARMACOSMOS HOLDING A/S (DK) | 2021-09-07 | — | — | US | disclosed |
| EP-3681539-A1 | IRON COMPLEX COMPOUNDS FOR THERAPEUTIC USE | Pharmacosmos Holding A/S (DK) | 2020-07-22 | — | — | EP | disclosed |
| CN-111050802-A | Iron complex compounds for therapeutic use | 法码科思莫斯控股有限公司 | 2020-04-21 | — | — | CN | disclosed |
| US-20190177353-A1 | IRON COMPLEX COMPOUNDS FOR THERAPEUTIC USE | PHARMACOSMOS HOLDING A/S (DK) | 2019-06-13 | — | — | US | disclosed |
| WO-2012175608-A1 | METHOD FOR MANUFACTURING HYDROXYETHYL STARCH DERIVATIVES | SERUMWERK BERNBURG AG (DE) | 2012-12-27 | — | — | WO | disclosed |
| EP-2537866-A1 | Hydroxyethyl starch derivatives, method for manufacturing the same and therapeutical uses thereof | Serumwerk Bernburg AG (DE) | 2012-12-26 | — | — | EP | disclosed |
| EP-0019403-B1 | HYDROXYALKYL-STARCH DRUG CARRIER | AMERICAN HOSPITAL SUPPLY CORPORATION (US) | 1985-07-31 | — | — | EP | disclosed |
| EP-0028641-B1 | HYDROXYALKYL STARCH DRUG CARRIER | AMERICAN HOSPITAL SUPPLY CORPORATION (US) | 1985-04-24 | — | — | EP | disclosed |
| EP-0028641-A4 | HYDROXYALKYL STARCH DRUG CARRIER. | AMERICAN HOSPITAL SUPPLY CORP (US) | 1981-09-01 | — | — | EP | disclosed |
| EP-0028641-A1 | HYDROXYALKYL STARCH DRUG CARRIER. | AMERICAN HOSPITAL SUPPLY CORP (US) | 1981-05-20 | — | — | EP | disclosed |
| EP-0019403-A2 | Hydroxyalkyl-starch drug carrier | AMERICAN HOSPITAL SUPPLY CORPORATION (US) | 1980-11-26 | — | — | EP | disclosed |
| WO-1980002374-A1 | HYDROXYALKYL STARCH DRUG CARRIER | AMERICAN HOSPITAL SUPPLY CORP (US) | 1980-11-13 | — | — | WO | disclosed |